China National Medicines Corporation Ltd. (SHA: 600511)

China National Medicines Corporation Statistics

Total Valuation

China National Medicines Corporation has a market cap or net worth of CNY 21.92 billion. The enterprise value is 15.74 billion.

Market Cap	21.92B
Enterprise Value	15.74B

Important Dates

The next estimated earnings date is Monday, October 21, 2024.

Earnings Date	Oct 21, 2024
Ex-Dividend Date	Jun 13, 2024

Share Statistics

China National Medicines Corporation has 754.50 million shares outstanding. The number of shares has decreased by -0.01% in one year.

Shares Outstanding	754.50M
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	12.40%
Float	324.11M

Valuation Ratios

The trailing PE ratio is 10.14 and the forward PE ratio is 8.78. China National Medicines Corporation's PEG ratio is 0.88.

PE Ratio	10.14
Forward PE	8.78
PS Ratio	0.44
PB Ratio	1.36
P/FCF Ratio	12.99
PEG Ratio	0.88

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.17, with an EV/FCF ratio of 9.32.

EV / Earnings	7.28
EV / Sales	0.31
EV / EBITDA	6.17
EV / EBIT	6.73
EV / FCF	9.32

Financial Position

The company has a current ratio of 2.03, with a Debt / Equity ratio of 3.44.

Current Ratio	2.03
Quick Ratio	1.67
Debt / Equity	3.44
Debt / EBITDA	0.24
Debt / FCF	0.37
Interest Coverage	109.57

Financial Efficiency

Return on equity (ROE) is 13.63% and return on invested capital (ROIC) is 8.27%.

Return on Equity (ROE)	13.63%
Return on Assets (ROA)	4.54%
Return on Capital (ROIC)	8.27%
Revenue Per Employee	16.03M
Profits Per Employee	688,950
Employee Count	3,138
Asset Turnover	1.56
Inventory Turnover	10.42

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.11% in the last 52 weeks. The beta is 0.40, so China National Medicines Corporation's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-9.11%
50-Day Moving Average	31.64
200-Day Moving Average	31.59
Relative Strength Index (RSI)	32.86
Average Volume (20 Days)	6,591,702

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, China National Medicines Corporation had revenue of CNY 50.31 billion and earned 2.16 billion in profits. Earnings per share was 2.87.

Revenue	50.31B
Gross Profit	3.88B
Operating Income	2.34B
Pretax Income	2.92B
Net Income	2.16B
EBITDA	2.44B
EBIT	2.34B
Earnings Per Share (EPS)	2.87

Balance Sheet

The company has 8.62 billion in cash and 617.22 million in debt, giving a net cash position of 8.00 billion or 10.60 per share.

Cash & Cash Equivalents	8.62B
Total Debt	617.22M
Net Cash	8.00B
Net Cash Per Share	10.60
Equity (Book Value)	17.94B
Book Value Per Share	21.37
Working Capital	14.82B

Cash Flow

In the last 12 months, operating cash flow was 1.83 billion and capital expenditures -138.91 million, giving a free cash flow of 1.69 billion.

Operating Cash Flow	1.83B
Capital Expenditures	-138.91M
Free Cash Flow	1.69B
FCF Per Share	2.24

Margins

Gross margin is 7.72%, with operating and profit margins of 4.65% and 4.30%.

Gross Margin	7.72%
Operating Margin	4.65%
Pretax Margin	5.81%
Profit Margin	4.30%
EBITDA Margin	4.86%
EBIT Margin	4.65%
FCF Margin	3.35%

Dividends & Yields

This stock pays an annual dividend of 0.85, which amounts to a dividend yield of 2.94%.

Dividend Per Share	0.85
Dividend Yield	2.94%
Dividend Growth (YoY)	9.21%
Years of Dividend Growth	2
Payout Ratio	35.09%
Buyback Yield	0.01%
Shareholder Yield	2.95%
Earnings Yield	9.86%
FCF Yield	7.70%

Stock Splits

The last stock split was on June 3, 2009. It was a forward split with a ratio of 2.

Last Split Date	Jun 3, 2009
Split Type	Forward
Split Ratio	2